Company Profile Offices Service Offered ISO certification quality policy knowledge center 20th anniversary 25th anniversary
Portfolio Management Depository Services NRI Cell Internet Trading Knowledge Center Gold etf Currency Trading CLIENT IPV(RM LOGIN)
Equity Derivatives IPO Insurance Currency
Morning Capstocks Conviction Ideas Monthly Recommendations Current Market Scenario IPO/NFO Synopsis Technical Ideas Disclosure of Research Ananlyst Annual Compliance Audit Report
Downloads News & Events

Market & News

graph-market Equity

ProgressImage ProgressImage
Ajanta Pharma Ltd
Pharmaceuticals - Indian - Formulations
BSE Code 532331 border-img ISIN Demat INE031B01049 border-img Book Value 290.17 border-img NSE Symbol AJANTPHARM border-img Div & Yield % 1.08 border-img Market Cap (₹ Cr.) 32625.69 border-img P/E 34.87 border-img EPS 74.9 border-img Face Value 2
BSE NSE
Last Price
2,611.40
Net Change
+72.10
Volume
10549
P / E
34.87
Stock Price Details (₹)
Last Price(₹) 2,611.40
Best Buy(₹) 0.00
Best Sell(₹) 0.00
Buy Quantity 0
Sell Quantity 0
Today's High(₹) 2,622.00
Today's Low(₹) 2,526.15
52-Week High(₹) 3,147.90
52-Week Low(₹) 2,022.05
Market Statistics
Div & Yield % 1.08
Eps 74.9
Book Value 290.1676063
Market Cap(Rs.Cr) 32,625.69
Face Value 2
Market Lot 1
AGM Date Jul
Book Closure Date
ISIN No. INE031B01049

Chart

  • 1 Day
  • 5 Day
  • 3 Mon
  • 1 Yr
  • 5 yr
News
Board of Ajanta Pharma recommends interim dividend
Ajanta Pharma consolidated net profit rises 20.19% in...
Ajanta Pharma fixes record date for 1st interim divid...
Ajanta Pharma gains after Q2 PAT jumps 20% YoY to Rs ...
Ajanta Pharma Ltd - Ajanta Pharma Limited - Analysts/...
Ajanta Pharma Ltd - Ajanta Pharma Limited - Address C...
Ajanta Pharma Ltd - Ajanta Pharma Limited - Outcome o...
Ajanta Pharma Ltd - Ajanta Pharma Limited - Record Date
Ajanta Pharma Ltd - Ajanta Pharma Limited - Dividend
Ajanta Pharma Ltd - Ajanta Pharma Limited - Dividend
Read More
Corporate Details
Incorporation Year : 1979
Chairman : Mannalal B Agrawal
Business Group : Indian Private
Registered Office :

Ajanta Pharma Ltd
Ajanta House,
Charkop Kandivli (W),
Mumbai,
Maharashtra - 400067,
Phone : 91-22-66061000/1204/1203,
Fax : 91-22-66061200/1300
E-Mail : info@ajantapharma.com; investorgrievance@ajantapha
URL : http://www.ajantapharma.com
Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges

BSE 500
BSE HC
BSE Midcap
CNX 500
CNX Pharma
 BSE
Kolkata
Chennai
Ahmedabad
Delhi
Kochi
x
capstocks-logo
 
Date & Time -( )
 

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account

MEMBERS IN : NSE, BSE, MCX – DP : CDSL – Portfolio ManagerHelpdesk: helpdesk@capstocks.com

SEBI registered broker Nos: NSE, BSE & MCX: INZ000165931 | DP: IN-DP-CDSL-203-2003 | PMS: INP000001066 | Research Entity SEBI Reg No: INH200003109, |
BSE Enlisted No: 5189 | Member ID : NSE: 11674, BSE : 3086, MCX : 55990

Investor Grievances : Customer.redressal@capstocksindia.com

GST Numbers

CIN No U67120KL2001PTC014680

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

© 2018 Capstocks and Securities(India) Pvt. LTD All rights reserved.

Designed, Developed and content powered by CMOTS Infotech( ISO 9001:2015 certified )

x
capstocks-logo
GST
 
x
Investment
 
×
Let's Chat
close
refresh